339
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

First trimester fasting plasma glucose screen in advanced maternal age women: a cost-effectiveness analysis

, ORCID Icon, ORCID Icon &
Pages 4123-4129 | Received 18 May 2020, Accepted 03 Nov 2020, Published online: 12 Nov 2020

References

  • Correa A, Bardenheier B, Elixhauser A, et al. Trends in prevalence of diabetes among delivery hospitalizations, United States, 1993-2009. Matern Child Health J. 2015;19(3):635–642.
  • Lawrence JM, Contreras R, Chen W, et al. Trends in the prevalence of preexisting diabetes and gestational diabetes mellitus among a racially/ethnically diverse population of pregnant women, 1999-2005. Diabetes Care. 2008;31(5):899–904.
  • Balasch J, Gratacos E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol. 2012;24(3):187–193.
  • Khalil A, Syngelaki A, Maiz N, et al. Maternal age and adverse pregnancy outcome: a cohort study. Ultrasound Obstet Gynecol. 2013;42(6):634–643.
  • Albrecht SS, Kuklina EV, Bansil P, et al. Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care. 2010;33(4):768–773.
  • Allen AJ, Snowden JM, Lau B, et al. Type-2 diabetes mellitus: does prenatal care affect outcomes? J Maternal-Fetal Neonat Med. 2018;31(1):93–97.
  • Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol. 2003;102(4):857–868.
  • Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352(24):2477–2486.
  • Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361(14):1339–1348.
  • Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002.
  • ACOG Practice bulletin No. 190: gestational diabetes mellitus. Am Coll Obstet Gynecol. 2018;131:e49–e64.
  • Screening for diabetes. Diabetes Care. 2002;25(1):s21–s24.
  • Caughey AB. Cost-effectiveness analysis of prenatal diagnosis: methodological issues and concerns. Gynecol Obstet Invest. 2005;60(1):11–18.
  • Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta (GA): Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2017.
  • Laopaiboon M, Lumbiganon P, Intarut N, et al. Advanced maternal age and pregnancy outcomes: a multicountry assessment. BJOG: Int J Obstet Gy. 2014;121:49–56.
  • Friedman SA, Schiff E, Kao L, et al. Neonatal outcome after preterm delivery for preeclampsia. Am Coll Obstet Gynecol. 1995;172(6):1785–1788.
  • Zapata-Masias Y, Marqueta B, Gomez Roig MD, et al. Obstetric and perinatal outcomes in women >/=40years of age: associations with fetal growth disorders. Early Human Develop. 2016;100:17–20.
  • Stotland NE, Caughey AB, Breed EM, et al. Risk factors and obstetric complications associated with macrosomia. Int J Gynaecol Obstet. 2004;87(3):220–226.
  • Ouzounian JG, Korst LM, Miller DA, et al. Brachial plexus palsy and shoulder dystocia: obstetric risk factors remain elusive. Am J Perinatol. 2013;30(4):303–307.
  • Boulet SL, Alexander GR, Salihu HM, et al. Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol. 2003;188(5):1372–1378.
  • Esakoff TF, Cheng YW, Sparks TN, et al. The association between birthweight 4000 g or greater and perinatal outcomes in patients with and without gestational diabetes mellitus. Am J Obstet Gynecol. 2009;200(6):672.e1–672.e4.
  • Kenny LC, Lavender T, McNamee R, et al. Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS One. 2013;8(2):e56583.
  • Surman G, Hemming K, Platt MJ, et al. Children with cerebral palsy: severity and trends over time. Paediatr Perinat Epidemiol. 2009;23(6):513–521.
  • Moore GP, Lemyre B, Barrowman N, et al. Neurodevelopmental outcomes at 4 to 8 years of children born at 22 to 25 weeks’ gestational age: a meta-analysis. JAMA Pediatr. 2013;167(10):967–974.
  • Lisonkova S, Joseph KS. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013;209(6):544.e1–544.e12.
  • Page JM, Snowden JM, Cheng YW, et al. The risk of stillbirth and infant death by each additional week of expectant management stratified by maternal age. Am J Obstet Gynecol. 2013;209(4):375.e1–375.e7.
  • Moster D, Wilcox AJ, Vollset SE, et al. Cerebral palsy among term and postterm births. JAMA. 2010;304(9):976–982.
  • Lai FY, Johnson JA, Dover D, et al. Outcomes of singleton and twin pregnancies complicated by pre-existing diabetes and gestational diabetes: a population-based study in Alberta, Canada, 2005-11. J Diabetes. 2016;8(1):45–55.
  • Wahabi HA, Alzeidan RA, Bawazeer GA, et al. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010;10:63.
  • Crisham Janik MD, Newman TB, Cheng YW, et al. Maternal diagnosis of obesity and risk of cerebral palsy in the child. J Pediatr. 2013;163(5):1307–1312.
  • Bureau of Labor Statistics USDoL [Internet]. The economics daily, consumer price index: 2017. Washington (DC): Bureau of Labor Statistics; 2017. Available from: https://www.bls.gov/opub/ted/2018/consumer-price-index-2017-in-review.htm.
  • Gillett M, Brennan A, Watson P, et al. The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study. Health Technol Assess. 2015;19(33):1–80.
  • Khalafallah A, Phuah E, Al-Barazan AM, et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open. 2016;6(4):e011059.
  • Gillespie P, Cullinan J, O’Neill C, et al. Modeling the independent effects of gestational diabetes mellitus on maternity care and costs. Diabetes Care. 2013;36(5):1111–1116.
  • Kitzmiller JL. Cost analysis of diagnosis and treatment of gestational diabetes mellitus. Clin Obstet Gynecol. 2000;43(1):140–153.
  • Lemieux J, Mulligan T. Trends in inpatient hospital prices, 2008-2010. Am J Managed Care. 2013;19(3):e106–e113.
  • Phibbs CS, Schmitt SK. Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants. Early Human Develop. 2006;82(2):85–95.
  • Wu O, Robertson L, Twaddle S, et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess. 2006;10(11):1–110.
  • Center for Disease Control. Economic costs associated with mental retardation CP, hearing loss, and vision impairment — United States, 2003. Atlanta (GA): U.S. Dept. of Health, Education, and Welfare, Public Health Service, Center for Disease Control. 2004.
  • Mission JF, Ohno MS, Cheng YW, et al. Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis. Am J Obstet Gynecol. 2012;207(4):326.e1–326.e9.
  • Rouse DJ, Owen J, Goldenberg RL, et al. The effectiveness and costs of elective cesarean delivery for fetal macrosomia diagnosed by ultrasound. JAMA. 1996;276(18):1480–1486.
  • Carroll AE, Downs SM. Comprehensive cost-utility analysis of newborn screening strategies. Pediatrics. 2006;117(5):S287–S295.
  • Grobman WA, Dooley SL, Welshman EE, et al. Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff? Prenat Diagn. 2002;22(13):1195–1200.
  • Kuppermann M, Nease RF, Learman LA, et al. Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women’s preferences. Obstet Gynecol. 2000;96(4):511–516.
  • Russell LB, Gold MR, Siegel JE, et al. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996;276(14):1172–1177.
  • Mathews TJ, Hamilton BE. Mean age of mothers is on the rise: United States, 2000-2014. NCHS data brief. 2016;232:1–8.
  • WHO. Classification of diabetes mellitus. Geneva (Switzerland): World Health Organization; 2019.
  • Alunni ML, Roeder HA, Moore TR, et al. First trimester gestational diabetes screening – Change in incidence and pharmacotherapy need. Diabetes Res Clin Pract. 2015;109(1):135–140.
  • Corrado F, D’Anna R, Cannata ML, et al. Correspondence between first-trimester fasting glycaemia, and oral glucose tolerance test in gestational diabetes diagnosis. Diabetes Metabol. 2012;38(5):458–461.
  • Riskin-Mashiah S, Damti A, Younes G, et al. First trimester fasting hyperglycemia as a predictor for the development of gestational diabetes mellitus. Euro J Obstet, Gynecol, Reproduct Biol. 2010;152(2):163–167.
  • Palatnik A, Mele L, Landon MB, et al. Timing of treatment initiation for mild gestational diabetes mellitus and perinatal outcomes. Am J Obstet Gynecol. 2015;213(4):560.e1.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.